Future studies using organoid models in conjunction with in vivo studies could help further address the differential dependencies for proximal vs. distal colon cancer development, as well as for KRAS and BRAF mutation-driven tumorigenesis. The gene discussed is KRAS; the disease is malignant colon neoplasm.